Synapse - Works

Results (4073)

STAT3 expression and clinical implications in de novo diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program

Meeting Abstract

Ok, C. Y.; Xu-Monette, Z.; Tzankov, A.; Visco, C.; Montes, S. M.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y.; Bhagat, G.; more...
Blood (2013)

Fulltext@MSK | Save

Anti-neoplastic effect of high affinity and covalent-binding microtubule stabilizing agents In AML cells sensitive and resistant by ABC-transporter overexpression

Meeting Abstract

Pera, B.; Jordi, M.; Hoya-Arias, R.; Díaz, J. F.; Fang, W.; Altmann, K. H.; Moore, M. A. S.
Blood (2013)

Fulltext@MSK | Save

Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia

Meeting Abstract

Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
Blood (2013)

Fulltext@MSK | Save

Msi2 directly regulates the TGF-β signaling pathway and myeloid lineage bias in hematopoietic stem cells

Meeting Abstract

Park, S. M.; Deering, R. P.; Lu, Y.; Patrick, T.; Shenoy, V.; Lianoglou, S.; Al-Shahrour, F.; Leslie, C.; Ebert, B. L.; Lengner, C.; more...
Blood (2013)

Fulltext@MSK | Save

Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL

Meeting Abstract

Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
Blood (2013)

Fulltext@MSK | Save

A bi-specific T cell engaging monoclonal antibody (mAb) derived from a TCR-Like mAB specific for WT1/HLA-A0201 (ESK-BiTE) shows a potent activity against human AML and Ph+ ALL in mouse models

Meeting Abstract

Pankov, D.; Dao, T.; Wang, Y.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Veomett, N.; Curcio, M.; Doubrovina, E.; O'Reilly, R. J.; more...
Blood (2013)

Fulltext@MSK | Save

IL-22 administration decreases intestinal GVHD pathology, increases intestinal stem cell recovery, and enhances immune reconstitution following allogeneic hematopoietic transplantation

Meeting Abstract

Mertelsmann, A. M.; Dudakov, J. A.; Velardi, E.; Hua, G.; Kreines, F. M.; Levy, E. R.; O'Connor, M.; Smith, O. M.; Kolesnick, R.; van den Brink, M. R. M.; more...
Blood (2013)

Fulltext@MSK | Save

FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
Blood (2013)

Fulltext@MSK | Save

Targeting oncogenic interleukein-7 receptor signaling with N-acetylcysteine in T-cell acute lymphoblastic leukemia

Meeting Abstract

Mansour, M. R.; Reed, C.; Eisenberg, A.; Tseng, J. C.; Yoda, A.; Rodig, S. J.; DeAngelo, D. J.; Sallan, S. E.; Weinstock, D. M.; Izraeli, S.; more...
Blood (2013)

Fulltext@MSK | Save

Combination therapy with mocetinostat, an oral, spectrum-selective histone deacetylase (HDAC) inhibitor, and 5-azaciditine: Indication of clinical activity in MDS

Meeting Abstract

Garcia Manero, G.; Selina, L.; Virginia, K.; Maureen, C.; Besa, E. C.; Rossetti, J. M.; Chao, R.; Humphrey, R.; Silverman, L. R.
Blood (2013)

Fulltext@MSK | Save